ChinaLin Securities Co., Ltd. (002945.SZ) Bundle
Curious whether ChinaLin Securities Co., Ltd. (002945.SZ) is positioned for investors seeking growth or value? The firm reported nine-month revenue of 1.19972 billion yuan (vs. 1.01601 billion yuan a year earlier) and TTM revenue of 1.57 billion yuan, with TTM revenue per share and latest-quarter revenue per share both at 2.81 yuan; management projected H1 2025 net profit of 270-350 million yuan (a year‑on‑year rise of 119%-184%), while June metrics show a net income of 233.23 million yuan and an exceptional June net profit margin of 50.46%; profitability and valuation paint a mixed picture-TTM net profit margin at 25.34%, EPS 0.18 yuan, P/E 82.09, P/B 5.57 and P/S 25.62-against a balance-sheet profile with total assets of 32.42 billion yuan, total liabilities around 25.34 billion yuan (latest quarter 22.076 billion), total equity 7.08 billion and a debt-to-equity ratio of 115.21%, plus strong cash dynamics (cash from operations 2.72 billion yuan, net change in cash 1.48 billion, investing cash flow -558.16 million, financing cash flow -688.10 million) while market capitalization sat at 40.1 billion yuan (down 7.94% year-over-year); read on to see how these concrete figures translate into risk, valuation and growth opportunities across investment trading, alternative and private equity, fixed income products, and venture capital services.
ChinaLin Securities Co., Ltd. (002945.SZ) - Revenue Analysis
- Projected net profit (H1 2025): 270-350 million yuan, up 119%-184% year-on-year.
- Revenue (9M ending Sep 30, 2025): 1,199.72 million yuan vs. 1,016.01 million yuan in same period prior year.
- TTM revenue (as of Dec 5, 2025): 1.57 billion yuan.
- Market capitalization (as of Dec 5, 2025): 40.1 billion yuan, down 7.94% year-over-year.
- TTM revenue per share (as of Dec 5, 2025): 2.81 yuan; latest quarter revenue per share: 2.81 yuan.
| Metric | Value | Period / Date |
|---|---|---|
| Projected Net Profit | 270-350 million yuan | H1 2025 |
| YoY Net Profit Change | +119% to +184% | H1 2025 vs H1 2024 |
| Revenue (9-month) | 1,199.72 million yuan | Jan-Sep 30, 2025 |
| Revenue (9-month prior) | 1,016.01 million yuan | Jan-Sep 30, 2024 |
| TTM Revenue | 1.57 billion yuan | As of Dec 5, 2025 |
| Market Capitalization | 40.1 billion yuan | As of Dec 5, 2025 |
| Market Cap YoY Change | -7.94% | Dec 5, 2025 vs prior year |
| TTM Revenue per Share | 2.81 yuan | As of Dec 5, 2025 |
| Latest Quarter Revenue per Share | 2.81 yuan | Latest quarter |
- Revenue growth drivers: fee-based brokerage services, asset management scaling, and underwriting/investment banking contributions reflected in sequential and year-over-year increases.
- Per-share metrics: a TTM revenue per share of 2.81 yuan signals revenue-generating efficiency relative to outstanding shares; compares to market cap of 40.1 billion yuan for valuation context.
- Investor considerations: strong H1 net profit uplift offsets a modest decline in market capitalization; revenue momentum through first nine months and TTM supports earnings outlook.
ChinaLin Securities Co., Ltd. (002945.SZ) - Profitability Metrics
Key trailing twelve-month (TTM) profitability figures for ChinaLin Securities Co., Ltd. as of December 5, 2025 reveal a business with strong operating margins but modest asset and equity returns, and a valuation that reflects growth expectations or market premium.
| Metric | TTM Value (as of 2025-12-05) | Notes / Interpretation |
|---|---|---|
| Net profit margin | 25.34% | High margin indicates solid profitability on revenue - likely driven by fee and trading income mix. |
| Return on assets (ROA) | 2.97% | Moderate ROA suggests asset-light operations typical of securities firms but room to improve asset efficiency. |
| Return on equity (ROE) | 6.82% | Subdued ROE relative to peers or market averages; equity leverage and capital allocation affect shareholder returns. |
| Earnings per share (EPS) | 0.18 CNY | Absolute EPS level; useful for trend analysis and valuation with share count context. |
| Price-to-earnings (P/E) | 82.09 | High P/E implies market is pricing significant future growth or there is limited current earnings upside. |
| Price-to-book (P/B) | 5.57 | P/B well above 1, indicating a premium to accounting book value - market expects intangible value or strong ROE recovery. |
- Profitability structure: 25.34% net margin shows core business yields healthy profits on revenues.
- Efficiency trade-off: ROA 2.97% vs. ROE 6.82% signals modest leverage and potential to boost equity returns via higher operational efficiency or returns on investments.
- Per-share performance: EPS 0.18 CNY provides a baseline for earnings growth expectations relative to the lofty P/E.
Valuation context and investor implications:
- High P/E (82.09) indicates the stock is priced for growth; investors should verify earnings sustainability and catalysts for multiple expansion.
- Elevated P/B (5.57) suggests market confidence in intangible assets, franchise value, or future profitability improvements-contrast with ROE to test consistency.
- Monitoring trends: if net margin remains >20% with improving ROA/ROE, the premium valuation may be justified; otherwise, margin and return compression risk could pressure multiples.
For ownership, activity and broader investor context, see: Exploring ChinaLin Securities Co., Ltd. Investor Profile: Who's Buying and Why?
ChinaLin Securities Co., Ltd. (002945.SZ) Debt vs. Equity Structure
Key balance-sheet snapshots and leverage metrics for ChinaLin Securities Co., Ltd. (002945.SZ) across reported dates and quarters.
| Metric | Value | As of |
|---|---|---|
| Reported debt-to-equity ratio | 115.21% | December 5, 2025 |
| Total liabilities | 25.34 billion yuan | June 2025 |
| Total assets | 32.42 billion yuan | June 2025 |
| Total equity | 7.08 billion yuan | June 2025 |
| Market capitalization | 40.1 billion yuan | December 5, 2025 |
| Total liabilities (latest quarter) | 22.076 billion yuan | Latest quarter |
- Reported leverage (115.21%) - company-stated or market-reported figure as of 2025-12-05.
- Balance-sheet snapshot (June 2025) shows total liabilities of 25.34 bn and equity of 7.08 bn - implying a liabilities-to-equity multiple materially above 100% on a simple ratio.
- Latest-quarter liabilities (22.076 bn) indicate some liability reduction from June 2025 levels.
Simple calculated leverage checkpoints (for quick investor reference):
| Calculation | Formula / Inputs | Result |
|---|---|---|
| Liabilities / Equity (June 2025) | 25.34 bn / 7.08 bn | ≈ 3.58x (≈ 358%) |
| Liabilities / Equity (latest quarter) | 22.076 bn / 7.08 bn | ≈ 3.12x (≈ 312%) |
| Assets / Liabilities (June 2025) | 32.42 bn / 25.34 bn | ≈ 1.28x |
| Equity / Assets (June 2025) | 7.08 bn / 32.42 bn | ≈ 21.8% |
| Market cap / Equity (price-to-book proxy) | 40.1 bn / 7.08 bn | ≈ 5.66x |
- High liabilities-to-equity multiples indicate the company operates with significant leverage versus shareholder capital; equity represents roughly 21.8% of assets (June 2025).
- Market capitalization well above book equity (≈5.66x) implies investors price future earnings/profitability expectations or intangible value beyond current book equity.
- Movement from 25.34 bn liabilities (June) to 22.076 bn (latest quarter) suggests liability deleveraging or seasonal/operational shifts; monitor trend across quarter filings.
For historical context, ownership, and how ChinaLin Securities generates revenue, see: ChinaLin Securities Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
ChinaLin Securities Co., Ltd. (002945.SZ) - Liquidity and Solvency
ChinaLin Securities shows strong short-term cash generation and a robust net profit margin as of June 2025, supported by substantial operating cash inflows and a sizable net increase in cash for the period.| Metric | Amount (CNY) | Period/Note |
|---|---|---|
| Net Profit Margin | 50.46% | June 2025 |
| Net Income | 233.23 million | June 2025 |
| Cash from Operations | 2.72 billion | June 2025 |
| Cash from Investing | -558.16 million | June 2025 |
| Cash from Financing | -688.10 million | June 2025 |
| Net Change in Cash | 1.48 billion | June 2025 |
- High net profit margin (50.46%) indicates strong profitability relative to revenue for the period.
- Operating cash inflow of 2.72 billion CNY provides clear evidence of cash-generating core business activities.
- Net income (233.23 million CNY) is positive but small relative to operating cash, suggesting non-cash items or timing differences bolstering cash flow.
- Negative investing cash flow (-558.16 million CNY) signals capital deployment or acquisitions; this is an investment in future capacity but reduces short-term liquidity.
- Negative financing cash flow (-688.10 million CNY) implies debt repayment, dividends, or share buybacks-actions that strengthen solvency but consume cash.
- Net change in cash of +1.48 billion CNY reinforces an improved liquidity position despite outgoing investing and financing uses.
- Key solvency implication: strong operating cash flow + net cash accumulation reduce short-term default risk and enhance the ability to service liabilities.
- Watch items: sustainability of >50% net profit margin and whether investing/financing outflows continue to increase cash burn over subsequent periods.
ChinaLin Securities Co., Ltd. (002945.SZ) - Valuation Analysis
Key valuation metrics as of December 5, 2025 (with balance sheet context through June 2025):
| Metric | Value | Notes / Source Date |
|---|---|---|
| TTM Price-to-Earnings (P/E) | 82.09 | As of 2025-12-05 |
| TTM Price-to-Book (P/B) | 5.57 | As of 2025-12-05 |
| TTM Price-to-Sales (P/S) | 25.62 | As of 2025-12-05 |
| Market Capitalization | 40.1 billion CNY | As of 2025-12-05 |
| Total Assets | 32.42 billion CNY | As of June 2025 |
| Total Liabilities | 25.34 billion CNY | As of June 2025 |
| Implied Shareholders' Equity (Assets - Liabilities) | 7.08 billion CNY | June 2025 |
| Implied Market-to-Book (Market Cap / Implied Equity) | ~5.66 | Consistent with reported P/B ≈ 5.57 |
- High P/E (82.09) signals strong growth expectations priced in or low trailing earnings; investors are paying a premium per unit of reported earnings.
- Elevated P/B (5.57) indicates the market values the firm substantially above its book equity-possible premium for intangibles, franchise value, or optimistic future profitability.
- Very high P/S (25.62) suggests revenue is valued at a steep multiple, reinforcing that earnings quality, recurring fee streams, or expected top-line expansion are being priced aggressively.
Interpretive considerations for investors:
- Leverage: with total liabilities of 25.34 billion CNY versus assets of 32.42 billion CNY, net equity is modest (~7.08 billion CNY), meaning leverage magnifies return volatility and downside risk.
- Market premium: market cap (40.1 billion CNY) far exceeds book equity, implying the market expects sustained outperformance relative to historical accounting profits.
- Valuation sensitivity: small changes in earnings or book value can materially affect multiples (given high baseline ratios), increasing valuation risk.
Quick comparative snapshot (for context):
| Measure | ChinaLin Securities | Implication |
|---|---|---|
| P/E (TTM) | 82.09 | Premium vs. typical broker-dealer peers |
| P/B | 5.57 | High market valuation over book |
| P/S | 25.62 | Revenue valued steeply |
| Market Cap | 40.1B CNY | Mid-cap on Chinese exchange scale |
For more on shareholder composition, trading behavior and who's buying, see: Exploring ChinaLin Securities Co., Ltd. Investor Profile: Who's Buying and Why?
ChinaLin Securities Co., Ltd. (002945.SZ) - Risk Factors
ChinaLin Securities' mid-2025 metrics show strong cash-generation but also concentrated exposures that investors should weigh. Key headline figures for June 2025:| Metric | June 2025 |
|---|---|
| Net profit margin | 50.46% |
| Net income | 233.23 million yuan |
| Net change in cash | 1.48 billion yuan |
| Cash from operations | 2.72 billion yuan |
| Cash from investing | -558.16 million yuan |
| Cash from financing | -688.10 million yuan |
- Concentration of profitability: A 50.46% net profit margin is unusually high for a securities firm-this can indicate one-off gains, accounting timing effects, or concentration in high-margin activities; sustainability is uncertain.
- Volatility in net income: Net income of 233.23 million yuan is healthy but could swing materially with market conditions, trading volumes, or underwriting cycles.
- Reliance on operating cash flows: Cash from operations at 2.72 billion yuan supports liquidity, yet large positive operating cash can disguise episodic receipts (e.g., settlement timing) that may reverse.
- Negative investing cash flow: Cash used in investing (-558.16 million yuan) suggests capital deployment or acquisitions - potential upside but also integration and execution risk.
- Negative financing cash flow: Cash used in financing (-688.10 million yuan) could reflect debt repayments or shareholder distributions; paydown reduces leverage but may constrain capital for growth.
- Cash buffer dynamics: Net change in cash of 1.48 billion yuan provides short-term cushioning, but sustained market stress could erode this buffer quickly.
- Market risk: As a securities firm, revenues are sensitive to market volatility, commission rates, and capital markets activity.
- Regulatory risk: Changes in securities regulation, capital requirements, or compliance costs can materially affect operations and margins.
- Counterparty and credit risk: Trading, repo, and margin businesses expose the firm to counterparty default and collateral valuation fluctuations.
- Operational risk: Systems, settlement, and execution failures could interrupt cash flows and impair client relationships.
- Liquidity risk: Despite current positive net cash change, concentrated client outflows or margin calls could pressure liquidity absent quick access to funding.
ChinaLin Securities Co., Ltd. (002945.SZ) - Growth Opportunities
ChinaLin Securities operates across multiple fee- and commission-bearing businesses and investment activities that present diversified growth vectors tied to China's capital markets expansion and alternative investment demand.- Core business lines: equity investment & trading; alternative & private equity investments; fixed income & other financial product investments; venture capital and corporate management consulting.
- Balance sheet scale: total assets of 32.42 billion yuan (June 2025).
- Market valuation: market capitalization of 40.1 billion yuan (5 Dec 2025).
- Market cap / total assets ratio: ~1.24x, indicating market pricing modestly above balance-sheet scale.
| Segment | Primary Revenue Driver | Relevant Metric / Note |
|---|---|---|
| Equity investment & trading | Trading commissions, principal gains | Benefit from rising A-share liquidity and institutional flow |
| Alternative & private equity investment | Management fees, carried interest | Growing demand for private capital; platform-scale dependent |
| Fixed income & other financial products | Distribution fees, interest margin | Yield curve and credit spread environment affect margins |
| Venture capital & corporate management consulting | Equity upside, advisory fees | Early-stage tech and healthcare remain high-growth targets |
- Growth catalysts:
- Higher market turnover amplifying brokerage and trading revenue.
- Scaling alternative asset platforms to secure recurring management fees and carry.
- Cross-selling between advisory, VC, and asset management to capture end-to-end client lifecycles.
- Macro-driven fixed income demand supporting product distribution and margin expansion.
- Balance sheet & capital deployment:
- Total assets 32.42 billion yuan provide a base for proprietary investments and product inventory.
- Market cap 40.1 billion yuan (5 Dec 2025) implies investor expectations for growth beyond current asset scale.

ChinaLin Securities Co., Ltd. (002945.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.